Renovos is backed decades of academic research and deep understanding of stem cells, tissue engineering and biomaterial fields. Renovos offers a portfolio of products to meet the needs of the regenerative medicine industry.
Renovos is addressing the unmet clinical needs within the regenerative medicine and orthopaedics space by developing a proprietary platform technology based on nanoclay gels, Renovite™. Renovite™ acts as injectable scaffold which attracts cells and localises and retains delivered biologics at ultra-low doses for safer and more efficient regenerative medicine applications.
Our commercial proposition includes primary mesenchymal stem cells for research, sourced from elderly and orthopaedic patient cohorts. We also support scientists with novel research solutions. We offer research services for screening and testing of novel biomaterials and compounds for biocompatibility, toxicology, angiogenesis and bone / cartilage regeneration.